A 12.5% duty sounds alarming — until you read what the investigation actually measured.
The proposed Section 301 tariff of 12.5% on Indian goods has grabbed market attention today, but the detail most coverage is skipping may matter more than the rate itself. The USTR’s investigation, launched in March 2026 and covering 60 economies, does not allege that Indian manufacturers use forced labour. Instead, it concludes that India has failed to impose and enforce a ban on importing goods made with forced labour from other countries — a regulatory gap, not a production accusation.
That distinction is critical for shareholders in export-heavy sectors. GTRI founder Ajay Srivastava has argued that the finding can be challenged precisely because the probe examined India’s import policy framework, not labour conditions on Indian factory floors. In other words, Indian textile mills, auto-component makers, and pharmaceutical manufacturers are not being accused of employing forced labour — they are being penalised because India’s customs regime does not explicitly screen inbound shipments for forced-labour origin the way the United States does under its own Tariff Act provisions dating back to the 1930s.
Why is the rate 12.5% and not 10%? The USTR carved out a lower 10% bracket for six economies — Canada, Ecuador, the European Union, Indonesia, Mexico, and Pakistan — that already have some form of forced-labour import prohibition on the books, even if enforcement is weak. The remaining 54 economies, including India, China, Japan, South Korea, the United Kingdom, and Australia, landed in the higher bracket because they lack even a partial statutory ban. That puts India in the same bucket as major allies of the US, a detail that dilutes the narrative of India-specific targeting.
What does the timeline look like? Written comments are due by 6 July, with public hearings set to begin on 7 July. Crucially, Assistant USTR Brendan Lynch is in New Delhi this week (1–4 June) to finalise the last stretch of the interim Bilateral Trade Agreement. Indian officials have indicated that both the proposed tariff rate and the Section 301 findings will feature in these talks. India had already formally denied the allegations during the comment period that closed in April and is expected to submit further objections before the July deadline.
Where does this sit in the broader tariff landscape? Since the US Supreme Court struck down the administration’s reciprocal tariffs in February 2026, Section 301 has become Washington’s primary legal route to reimpose duties. For context, Indian exporters already navigated tariffs rising from 10% to as high as 50% between April and August 2025, which GTRI estimates contributed to a roughly 37% decline in exports to the US over that stretch. The current 12.5% proposal, if finalised, would stack on top of whatever baseline duty emerges from the ongoing BTA negotiations — making the effective rate the number investors should watch, not the headline figure alone.
What should investors verify before reacting?
- Whether your portfolio’s export-oriented companies derive significant US revenue and in which product categories — beef, coffee, and certain fruits and nuts are exempt from this proposal.
- The outcome of the July 7 hearings and whether India secures a carve-out or reclassification into the 10% bracket by enacting even a partial forced-labour import ban.
- The final text of the India-US interim BTA, which could offset or complicate the Section 301 duty through separate tariff commitments — India’s February 2026 joint statement pledged over $500 billion in US purchases over five years.
For a broader look at how India’s trade policy is evolving under sustained US pressure, read our earlier analysis on India’s shifting export strategy amid tariff escalation. For the full text of the USTR’s Section 301 findings, visit the Office of the US Trade Representative.
Disclaimer: This article is journalism and educational commentary, not investment advice. The author is not a SEBI-registered Research Analyst. Figures should be independently verified against official filings before any financial decision.
Found this breakdown useful? Share it with a fellow investor who tracks India-US trade developments.
